Kidney transplantation is the treatment of choice for patients with end-stage kidney failure. However, the life of a kidney transplant is limited due to unrecognized immune injury. There is no sensitive, non-invasive method to detect this injury at an early-stage. We have developed a reliable, inexpensive, and noninvasive assay to monitor kidney injury.
Location: Australia, Queensland, Brisbane
Employees: 11-50
Founded date: 2017
Founders name: Joshua Yang
Founders Related Locations: United States, California, Palo Alto; United States, California, San Francisco
Investors 1
| Date | Name | Website |
| - | DaVita Ven... | davitavent... |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Joshua | Yang | Co-Founder | linkedin.c... | - | - |
Mentions in press and media 1
| Date | Title | Description |
| 22.09.2021 | Meet Michele Colucci, founder and managing partner at DigitalDx Ventures | DigitalDx Ventures invests in AI and data enabled diagnostics companies Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more startups th... |